PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DB26FDSMN4569770630!menveo 1 vial-a-c-y-w-135-dip 0.5ml — Amerisourcebergen Drug Corp

Amerisourcebergen Drug Corp holds $19.3B across 1,357,999 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DB24D2205. PoP ended Oct 21, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support

Awarding office

Amerisourcebergen Drug Corp

Recipient

Oct 21, 2025

PoP end

$185K

Obligated

$185K

Potential

424210

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Amerisourcebergen Drug Corp — $90

Contract facts

Federal

Contract numberSPE2DB26FDSMN

Also listed asSPE2DB24D2205-SPE2DB26FDSMN

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAmerisourcebergen Drug Corp

CAGE1XUY5

UEIKABZK8W6PQT3

NAICS424210

No full NAICS 424210 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2DB24D2205

Place of performanceCONSHOHOCKEN PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startOct 20, 2025

PoP end (current)Oct 21, 2025

Obligated$185K

Current value$185K

Potential value$185K

4569770630!MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML is a federal award for Dla Troop Support held by Amerisourcebergen Drug Corp. Estimated value $185K ($185K obligated). Current period of performance ends Oct 21, 2025. Place of performance: CONSHOHOCKEN PA.

4569770630!MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML

Recompete timing

Public

● Past PoP end (304 days ago)

Current PoP ended Oct 21, 2025 (304 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Amerisourcebergen Drug Corp — $19.3B obligated across 1,357,999 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($19.3B) · all agencies

Department of Defense (DOD)$19.3B · 100%Department of Health and Human Services (HHS)$7.6M · 0%Department of Veterans Affairs (VA)$5.9M · 0%Department of Justice (DOJ)$68K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C77026P0121

DROSPIRENONE

$321K

Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2DB26FDSMN?

SPE2DB26FDSMN (4569770630!menveo 1 vial-a-c-y-w-135-dip 0.5ml) is a Dla Troop Support award with a potential value of $185K, currently held by Amerisourcebergen Drug Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DB26FDSMN?

Dla Troop Support awarded SPE2DB26FDSMN to Amerisourcebergen Drug Corp (potential $185K).

Who is the incumbent on SPE2DB26FDSMN?

Amerisourcebergen Drug Corp is the incumbent with $19.3B across 1357999 related awards in SCOUT’s public footprint. The current period of performance ends Oct 21, 2025.

When does Amerisourcebergen Drug Corp’s SPE2DB26FDSMN come up for recompete?

SCOUT tracks a period-of-performance end of Oct 21, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 11, 2026 · refreshed monthlyLatest procurement action Oct 20, 2025